Top compounds associated with response to RP11-96O20.4


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.04
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.04
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC -0.076 0.04
mRNA tandutinib CTRPv2 pan-cancer AAC -0.074 0.04
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.071 0.04
mRNA DBeQ CTRPv2 pan-cancer AAC -0.076 0.04
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.05
mRNA IU1 CTRPv2 pan-cancer AAC -0.079 0.05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.05
Download CSV